Hashtag
The Times

Clarity's theranostic prostate cancer trial advances to highest dose level

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights

  • Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with 67Cu SAR-bisPSMA at the dose level of 8GBq.
  • No dose limiting toxicities (DLTs) have been reported in cohort 2.
  • The Safety Review Committee (SRC)...

Read more: Clarity's theranostic prostate cancer trial advances to highest dose level

Health & Wellness

What Do Clinical Teams Need from Their Surgical Supply Partners?

Hashtag.net.au - avatar Hashtag.net.au

In clinical settings, surgical supply partners aren’t just vendors. They sit quietly behind the scenes of operating lists, specialist consultations, treatment rooms and recovery workflows. When they...

The Growing Focus on Communication Development in Children

Hashtag.net.au - avatar Hashtag.net.au

The early developmental years of a child's life represent a critical window for neurological growth, behavioural shaping, and language acquisition. During this formative phase, the ability to interpre...

Looking for a Family Dentist in Sydney? Here's What To Consider

Hashtag.net.au - avatar Hashtag.net.au

Finding the right family dentist in Sydney is one of the most important health decisions you can make for your household. With hundreds of practices spread across the city — from Beecroft to Bondi, Pa...

hacklink hack forum hacklink film izle hacklink grandpashabetgrandpashabet电子书下载zlibraryDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026Grandpashabetmarsbahis girişbahiscasinobetparkaresbetmarsbahisbahiscasinoultrabetgrandpashabettarafbetpashagaming girişesim usajojobetcasibomholiganbetcasibomjojobetjojobetcasibomjojobetcratosroyalbetdeneme bonusujojobetjojobetjojobetholiganbet